BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ranchoux B, Nadeau V, Bourgeois A, Provencher S, Tremblay É, Omura J, Coté N, Abu-Alhayja'a R, Dumais V, Nachbar RT, Tastet L, Dahou A, Breuils-Bonnet S, Marette A, Pibarot P, Dupuis J, Paulin R, Boucherat O, Archer SL, Bonnet S, Potus F. Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease. Circ Res 2019;125:449-66. [PMID: 31154939 DOI: 10.1161/CIRCRESAHA.118.314555] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Selle J, Dinger K, Jentgen V, Zanetti D, Will J, Georgomanolis T, Vohlen C, Wilke R, Kojonazarov B, Klymenko O, Mohr J, V Koningsbruggen-Rietschel S, Rhodes CJ, Ulrich A, Hirani D, Nestler T, Odenthal M, Mahabir E, Nayakanti S, Dabral S, Wunderlich T, Priest J, Seeger W, Dötsch J, Pullamsetti SS, Alejandre Alcazar MA. Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life. Nat Commun 2022;13:4352. [PMID: 35896539 DOI: 10.1038/s41467-022-31655-z] [Reference Citation Analysis]
2 Boucherat O, Agrawal V, Lawrie A, Bonnet S. The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure. Circ Res 2022;130:1466-86. [PMID: 35482834 DOI: 10.1161/CIRCRESAHA.121.319971] [Reference Citation Analysis]
3 Huston JH, Shah SJ. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease. Circ Res 2022;130:1382-403. [PMID: 35482841 DOI: 10.1161/CIRCRESAHA.122.319967] [Reference Citation Analysis]
4 Funk-hilsdorf TC, Behrens F, Grune J, Simmons S. Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer. Front Physiol 2022;13:819145. [DOI: 10.3389/fphys.2022.819145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu S, Yan Y. Animal models of pulmonary hypertension due to left heart disease. Anim Models and Exp Med. [DOI: 10.1002/ame2.12214] [Reference Citation Analysis]
6 Luongo F, Miotti C, Scoccia G, Papa S, Manzi G, Cedrone N, Toto F, Malerba C, Papa G, Caputo A, Manguso G, Adamo F, Carmine DV, Badagliacca R. Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension. Heart Fail Rev. [DOI: 10.1007/s10741-021-10208-4] [Reference Citation Analysis]
7 Lajoie AC, Potus F. Sirtuin 3 and Uncouplin Protein 2, the Missing Link Between Genetics, Metabolism, and Pulmonary Arterial Hypertension. J Am Heart Assoc 2021;10:e023065. [PMID: 34724803 DOI: 10.1161/JAHA.121.023065] [Reference Citation Analysis]
8 Zhang C, Zheng D, Feng W, Zhang H, Han F, He W, Liu A, Huang H, Chen J. Olanzapine: Association Between a Typical Antipsychotic Drug and Aortic Calcification. Front Cardiovasc Med 2021;8:710090. [PMID: 34568454 DOI: 10.3389/fcvm.2021.710090] [Reference Citation Analysis]
9 Gonçalves AESS, Rocha GZ, Marin R, Camargo RL, Dos Santos A, do Carmo H, Guadagnini D, Petrucci O, Moysés ZP, Salemi VMC, Oliveira AG, Saad MJA. Pulmonary Hypertension in Obese Mice Is Accompanied by a Reduction in PPAR-γ Expression in Pulmonary Artery. Front Endocrinol (Lausanne) 2021;12:701994. [PMID: 34552556 DOI: 10.3389/fendo.2021.701994] [Reference Citation Analysis]
10 Campos-Martins A, Bragança B, Correia-de-Sá P, Fontes-Sousa AP. Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction. Front Pharmacol 2021;12:724320. [PMID: 34489711 DOI: 10.3389/fphar.2021.724320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Yi L, Liu J, Deng M, Zuo H, Li M. Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis. BMC Pulm Med 2021;21:252. [PMID: 34332565 DOI: 10.1186/s12890-021-01616-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Maeder MT, Weber L, Buser M, Brenner R, Joerg L, Rickli H. Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction. Front Cardiovasc Med 2021;8:694240. [PMID: 34307506 DOI: 10.3389/fcvm.2021.694240] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Feng X, Chen W, Ni X, Little PJ, Xu S, Tang L, Weng J. Metformin, Macrophage Dysfunction and Atherosclerosis. Front Immunol 2021;12:682853. [PMID: 34163481 DOI: 10.3389/fimmu.2021.682853] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
14 Sun B, Ying S, Ma Q, Li H, Li J, Song J. Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim D, Roberts C, McKenzie A, George MP. Nutritional ketosis to treat pulmonary hypertension associated with obesity and metabolic syndrome: a case report. Pulm Circ 2021;11:2045894021991426. [PMID: 33643610 DOI: 10.1177/2045894021991426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Papathanasiou AE, Spyropoulos F, Michael Z, Joung KE, Briana DD, Malamitsi-Puchner A, Mantzoros CS, Christou H. Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension. Int J Mol Sci 2021;22:1435. [PMID: 33535425 DOI: 10.3390/ijms22031435] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Wang S, Guo F, Sun X, Song X, Yuan Y, Zhang C, Lin G, Sheng H. Study on the Potential Mechanism of Fructus Tribuli in the Treatment of Hypertensive Vascular Remodeling Based on Network Pharmacology and Molecular Docking. Evid Based Complement Alternat Med 2021;2021:8862176. [PMID: 33505509 DOI: 10.1155/2021/8862176] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Bermejo J, González-Mansilla A, Mombiela T, Fernández AI, Martínez-Legazpi P, Yotti R, García-Orta R, Sánchez-Fernández PL, Castaño M, Segovia-Cubero J, Escribano-Subias P, Alberto San Román J, Borrás X, Alonso-Gómez A, Botas J, Crespo-Leiro MG, Velasco S, Bayés-Genís A, López A, Muñoz-Aguilera R, Jiménez-Navarro M, González-Juanatey JR, Evangelista A, Elízaga J, Martín-Moreiras J, González-Santos JM, Moreno-Escobar E, Fernández-Avilés F; SIOVAC (“Sildenafil for Improving Outcomes after VAlvular Correction”) Investigators. Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival. J Am Heart Assoc 2021;10:e019949. [PMID: 33399006 DOI: 10.1161/JAHA.120.019949] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
19 Todd N, Lai YC. Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease. Front Med (Lausanne) 2020;7:570016. [PMID: 33117832 DOI: 10.3389/fmed.2020.570016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Mulkareddy V, Simon MA. Metformin in Pulmonary Hypertension in Left Heart Disease. Front Med (Lausanne) 2020;7:425. [PMID: 32974359 DOI: 10.3389/fmed.2020.00425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Hanthazi A, Jespers P, Vegh G, Dubois C, Hubesch G, Springael JY, Dewachter L, Mc Entee K. Chemerin Added to Endothelin-1 Promotes Rat Pulmonary Artery Smooth Muscle Cell Proliferation and Migration. Front Physiol 2020;11:926. [PMID: 32848866 DOI: 10.3389/fphys.2020.00926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ning D, Du J, Yang XQ, Wang DX. More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2020;201:388-9. [PMID: 31560566 DOI: 10.1164/rccm.201908-1628LE] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Floy ME, Mateyka TD, Foreman KL, Palecek SP. Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine. Stem Cell Res 2020;45:101831. [PMID: 32446219 DOI: 10.1016/j.scr.2020.101831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wang L, Halliday G, Huot JR, Satoh T, Baust JJ, Fisher A, Cook T, Hu J, Avolio T, Goncharov DA, Bai Y, Vanderpool RR, Considine RV, Bonetto A, Tan J, Bachman TN, Sebastiani A, McTiernan CF, Mora AL, Machado RF, Goncharova EA, Gladwin MT, Lai YC. Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Arterioscler Thromb Vasc Biol 2020;40:1543-58. [PMID: 32268788 DOI: 10.1161/ATVBAHA.119.313883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
25 Maron BA, Leopold JA, Hemnes AR. Metabolic syndrome, neurohumoral modulation, and pulmonary arterial hypertension. Br J Pharmacol 2020;177:1457-71. [PMID: 31881099 DOI: 10.1111/bph.14968] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
26 Latimer LE, Duiverman M, Abdel-Aziz MI, Caliskan G, Mensink-Bout SM, Mendoza-Valderrey A, Justet A, Omura J, Srikanthan K, De Brandt J. ERS International Congress 2019: highlights from Best Abstract awardees. Breathe (Sheff) 2019;15:e143-9. [PMID: 32269637 DOI: 10.1183/20734735.0330-2019] [Reference Citation Analysis]
27 Huynh DTN, Jin Y, Heo K. Therapeutic targets and drugs for hyper-proliferation of vascular smooth muscle cells. J Pharm Investig 2020;50:337-47. [DOI: 10.1007/s40005-019-00469-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Fernández AI, Yotti R, González-Mansilla A, Mombiela T, Gutiérrez-Ibanes E, Pérez Del Villar C, Navas-Tejedor P, Chazo C, Martínez-Legazpi P, Fernández-Avilés F, Bermejo J. The Biological Bases of Group 2 Pulmonary Hypertension. Int J Mol Sci 2019;20:E5884. [PMID: 31771195 DOI: 10.3390/ijms20235884] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
29 Brittain EL, Hemnes AR. Moment on the Lips, a Lifetime on the Lungs?: Improving Models of Group 2 Pulmonary Hypertension. Circ Res 2019;125:467-9. [PMID: 31518172 DOI: 10.1161/CIRCRESAHA.119.315478] [Reference Citation Analysis]